Published in Pediatr Nephrol on October 22, 2008
Baseline BMI is a strong predictor of nadir BMI after adolescent gastric bypass. J Pediatr (2010) 1.61
Obesity-related glomerulopathy: body mass index and proteinuria. Clin J Am Soc Nephrol (2010) 1.54
Scope and mechanisms of obesity-related renal disease. Curr Opin Nephrol Hypertens (2010) 1.20
Adiponectin promotes functional recovery after podocyte ablation. J Am Soc Nephrol (2013) 1.09
Causes and pathogenesis of focal segmental glomerulosclerosis. Nat Rev Nephrol (2014) 0.94
Focal segmental glomerulosclerosis: molecular genetics and targeted therapies. BMC Nephrol (2015) 0.90
Kidney function in severely obese adolescents undergoing bariatric surgery. Obesity (Silver Spring) (2014) 0.82
Is obesity a risk factor for chronic kidney disease in children? Pediatr Nephrol (2012) 0.80
The effects of weight change on glomerular filtration rate. Nephrol Dial Transplant (2015) 0.79
Cardiovascular and renal effects of weight reduction in obesity and the metabolic syndrome. Curr Hypertens Rep (2015) 0.79
Metabolic syndrome in children with chronic kidney disease and after renal transplantation. Pediatr Nephrol (2013) 0.78
Histological deterioration of obesity-related glomerulopathy despite the loss of proteinuria with weight reduction. Pediatr Nephrol (2010) 0.77
Impact of obesity on kidney function and blood pressure in children. World J Nephrol (2015) 0.76
Bariatric Surgery and Kidney-Related Outcomes. KI Rep (2017) 0.75
Bariatric surgery and the kidney-much benefit, but also potential harm. Clin Kidney J (2012) 0.75
Proteinuria rebound in IgA nephropathy associated with obesity-related glomerulopathy. CEN Case Rep (2015) 0.75
Secondary Focal Segmental Glomerulosclerosis: From Podocyte Injury to Glomerulosclerosis. Biomed Res Int (2016) 0.75
Tools for Successful Weight Management in Primary Care. Am J Med Sci (2015) 0.75
Prevalence of overweight and obesity in the United States, 1999-2004. JAMA (2006) 72.59
Cardiovascular risk factors and excess adiposity among overweight children and adolescents: the Bogalusa Heart Study. J Pediatr (2007) 9.60
Adipose tissue: from lipid storage compartment to endocrine organ. Diabetes (2006) 5.25
Podocyte depletion causes glomerulosclerosis: diphtheria toxin-induced podocyte depletion in rats expressing human diphtheria toxin receptor transgene. J Am Soc Nephrol (2005) 4.79
Pathologic classification of focal segmental glomerulosclerosis: a working proposal. Am J Kidney Dis (2004) 4.20
Increases in clinically severe obesity in the United States, 1986-2000. Arch Intern Med (2003) 3.99
Obesity-related glomerulopathy: an emerging epidemic. Kidney Int (2001) 3.98
Clinical practice. Overweight children and adolescents. N Engl J Med (2005) 3.85
Adiponectin regulates albuminuria and podocyte function in mice. J Clin Invest (2008) 3.11
Activation of the systemic and adipose renin-angiotensin system in rats with diet-induced obesity and hypertension. Am J Physiol Regul Integr Comp Physiol (2004) 2.11
Proteinuria and focal segmental glomerulosclerosis in severely obese adolescents. J Pediatr (2001) 1.72
Adverse renal consequences of obesity. Am J Physiol Renal Physiol (2008) 1.62
Glomerular hypertrophy in minimal change disease predicts subsequent progression to focal glomerular sclerosis. Kidney Int (1990) 1.38
The nephrotic syndrome: a complication of massive obesity. Ann Intern Med (1974) 1.26
Overexpression of the renin-angiotensin system in human visceral adipose tissue in normal and overweight subjects. Am J Hypertens (2002) 1.24
One-year outcomes of Roux-en-Y gastric bypass for morbidly obese adolescents: a multicenter study from the Pediatric Bariatric Study Group. J Pediatr Surg (2006) 1.23
Tissue-specific nutritional regulation of angiotensinogen in adipose tissue. Hypertension (1992) 1.23
Extreme pediatric obesity: weighing the health dangers. J Pediatr (2007) 1.17
Plasma angiotensinogen concentrations in obese patients. Am J Hypertens (1997) 1.11
Clinical features and long-term outcome of obesity-associated focal segmental glomerulosclerosis. Nephrol Dial Transplant (2001) 1.09
Podocyte lesions in patients with obesity-related glomerulopathy. Am J Kidney Dis (2006) 1.06
The adipose renin-angiotensin system modulates systemic markers of insulin sensitivity and activates the intrarenal renin-angiotensin system. J Biomed Biotechnol (2006) 1.04
Angiotensinogen levels and obesity in four black populations. ICSHIB Investigators. J Hypertens (1998) 0.99
Evidence for a pathogenic linkage between glomerular hypertrophy and sclerosis. Am J Kidney Dis (1991) 0.99
High-molecular weight adiponectin isoforms increase after biliopancreatic diversion in obese subjects. Obesity (Silver Spring) (2006) 0.96
Role of podocytes in focal sclerosis: defining the point of no return. J Am Soc Nephrol (2005) 0.94
Dietary weight loss decreases serum angiotensin-converting enzyme activity in obese adults. Obes Res (2002) 0.92
An increase in plasma adiponectin multimeric complexes follows hypocaloric diet-induced weight loss in obese and overweight pre-menopausal women. Clin Sci (Lond) (2007) 0.88
The classification of glomerulonephritis in systemic lupus erythematosus revisited. J Am Soc Nephrol (2004) 7.38
Genome sequence and analysis of the Irish potato famine pathogen Phytophthora infestans. Nature (2009) 6.44
The classification of glomerulonephritis in systemic lupus erythematosus revisited. Kidney Int (2004) 4.77
Task Group 142 report: quality assurance of medical accelerators. Med Phys (2009) 4.32
Mutations in kelch-like 3 and cullin 3 cause hypertension and electrolyte abnormalities. Nature (2012) 4.26
Pathologic classification of focal segmental glomerulosclerosis: a working proposal. Am J Kidney Dis (2004) 4.20
Molecular architecture of the Goodpasture autoantigen in anti-GBM nephritis. N Engl J Med (2010) 3.78
Pathologic classification of diabetic nephropathy. J Am Soc Nephrol (2010) 3.61
Endothelial nitric oxide synthase deficiency produces accelerated nephropathy in diabetic mice. J Am Soc Nephrol (2006) 3.19
JC polyoma virus interacts with APOL1 in African Americans with nondiabetic nephropathy. Kidney Int (2013) 3.09
Serial determination of glomerular filtration rate in conscious mice using FITC-inulin clearance. Am J Physiol Renal Physiol (2003) 3.06
C3 glomerulopathy: consensus report. Kidney Int (2013) 2.85
Characterization of susceptibility of inbred mouse strains to diabetic nephropathy. Diabetes (2005) 2.67
Association of histologic variants in FSGS clinical trial with presenting features and outcomes. Clin J Am Soc Nephrol (2012) 2.42
Genetic engineering of glomerular sclerosis in the mouse via control of onset and severity of podocyte-specific injury. J Am Soc Nephrol (2005) 2.33
Dysfunctional high-density lipoprotein in patients on chronic hemodialysis. J Am Coll Cardiol (2012) 2.21
The Oxford IgA nephropathy clinicopathological classification is valid for children as well as adults. Kidney Int (2010) 2.14
Falling-edge, variable threshold (FEVT) method for the automated detection of gastric slow wave events in high-resolution serosal electrode recordings. Ann Biomed Eng (2009) 2.09
Spinal cord tolerance for stereotactic body radiotherapy. Int J Radiat Oncol Biol Phys (2009) 2.08
Transforming growth factor-beta-dependent and -independent pathways of induction of tubulointerstitial fibrosis in beta6(-/-) mice. Am J Pathol (2003) 2.05
Model of robust induction of glomerulosclerosis in mice: importance of genetic background. Kidney Int (2003) 1.94
Regression of glomerulosclerosis with high-dose angiotensin inhibition is linked to decreased plasminogen activator inhibitor-1. J Am Soc Nephrol (2005) 1.94
Sirt1 activation protects the mouse renal medulla from oxidative injury. J Clin Invest (2010) 1.90
Prevention of obesity and insulin resistance in mice lacking plasminogen activator inhibitor 1. Diabetes (2004) 1.85
Plasminogen activator inhibitor-1 in chronic kidney disease: evidence and mechanisms of action. J Am Soc Nephrol (2006) 1.82
Characterization of renal progenitors committed toward tubular lineage and their regenerative potential in renal tubular injury. Stem Cells (2012) 1.78
Podocyte injury damages other podocytes. J Am Soc Nephrol (2011) 1.75
Endoluminal GERD treatments: critical appraisal of current literature with evidence-based medicine instruments. Surg Endosc (2007) 1.74
Intrafractional motion of the prostate during hypofractionated radiotherapy. Int J Radiat Oncol Biol Phys (2008) 1.73
Hypertensive nephrosclerosis in African Americans versus Caucasians. Kidney Int (2002) 1.69
Distinct epitopes for anti-glomerular basement membrane alport alloantibodies and goodpasture autoantibodies within the noncollagenous domain of alpha3(IV) collagen: a janus-faced antigen. J Am Soc Nephrol (2005) 1.69
APOL1 Genotype and Kidney Transplantation Outcomes From Deceased African American Donors. Transplantation (2016) 1.68
Surgical removal of omental fat does not improve insulin sensitivity and cardiovascular risk factors in obese adults. Gastroenterology (2010) 1.62
Dystroglycan in the diagnosis of FSGS. Clin J Am Soc Nephrol (2009) 1.60
Aldosterone deficiency and mineralocorticoid receptor antagonism prevent angiotensin II-induced cardiac, renal, and vascular injury. Kidney Int (2012) 1.60
Renal biopsy findings among Indigenous Australians: a nationwide review. Kidney Int (2012) 1.56
Unexplained nephrotic-range proteinuria in a 38-year-old man: a case of "no change disease". Am J Kidney Dis (2004) 1.54
100 consecutive minimally invasive Heller myotomies: lessons learned. Ann Surg (2002) 1.53
Validation of the Oxford classification of IgA nephropathy. Kidney Int (2011) 1.53
Genome-wide association scan for survival on dialysis in African-Americans with type 2 diabetes. Am J Nephrol (2011) 1.52
Conditional knockout of macrophage PPARgamma increases atherosclerosis in C57BL/6 and low-density lipoprotein receptor-deficient mice. Arterioscler Thromb Vasc Biol (2005) 1.50
Distinct subpopulations of FOXD1 stroma-derived cells regulate renal erythropoietin. J Clin Invest (2016) 1.49
Absence of angiotensin II type 1 receptor in bone marrow-derived cells is detrimental in the evolution of renal fibrosis. J Clin Invest (2002) 1.45
Pharmacological inhibition and genetic deficiency of plasminogen activator inhibitor-1 attenuates angiotensin II/salt-induced aortic remodeling. Arterioscler Thromb Vasc Biol (2004) 1.44
Proteomic patterns and prediction of glomerulosclerosis and its mechanisms. J Am Soc Nephrol (2005) 1.44
Expression of HIV-1 genes in podocytes alone can lead to the full spectrum of HIV-1-associated nephropathy. Kidney Int (2005) 1.42
Genetic and environmental factors associated with type 2 diabetes and diabetic vascular complications. Rev Diabet Stud (2012) 1.42
HIV-1 genes vpr and nef synergistically damage podocytes, leading to glomerulosclerosis. J Am Soc Nephrol (2006) 1.35
Lack of integrin alpha1beta1 leads to severe glomerulosclerosis after glomerular injury. Am J Pathol (2004) 1.33
Regression of existing glomerulosclerosis by inhibition of aldosterone. J Am Soc Nephrol (2005) 1.31
Nephrotic syndrome complicating alpha-glucosidase replacement therapy for Pompe disease. Pediatrics (2004) 1.31
Cell senescence in the aging kidney. J Am Soc Nephrol (2010) 1.30
Stereotactic body radiotherapy as monotherapy or post-external beam radiotherapy boost for prostate cancer: technique, early toxicity, and PSA response. Int J Radiat Oncol Biol Phys (2010) 1.29
Permanent genetic tagging of podocytes: fate of injured podocytes in a mouse model of glomerular sclerosis. J Am Soc Nephrol (2005) 1.28
Elevated levels of plasma mitochondrial DNA DAMPs are linked to clinical outcome in severely injured human subjects. Ann Surg (2013) 1.27
Pathology of human diabetic nephropathy. Contrib Nephrol (2011) 1.26
Membranous nephropathy with crescents. J Am Soc Nephrol (2011) 1.25
Models of chronic kidney disease. Drug Discov Today Dis Models (2010) 1.24
Is Roux-en-Y gastric bypass surgery the most effective treatment for type 2 diabetes mellitus in morbidly obese patients? J Gastrointest Surg (2005) 1.23
The PPARgamma agonist pioglitazone ameliorates aging-related progressive renal injury. J Am Soc Nephrol (2009) 1.22
Transiently heightened angiotensin II has distinct effects on atherosclerosis and aneurysm formation in hyperlipidemic mice. Atherosclerosis (2005) 1.22
Gene-gene interactions in APOL1-associated nephropathy. Nephrol Dial Transplant (2013) 1.21
Scope and mechanisms of obesity-related renal disease. Curr Opin Nephrol Hypertens (2010) 1.20
Probabilities of radiation myelopathy specific to stereotactic body radiation therapy to guide safe practice. Int J Radiat Oncol Biol Phys (2012) 1.20
Reirradiation human spinal cord tolerance for stereotactic body radiotherapy. Int J Radiat Oncol Biol Phys (2010) 1.20
TCF7L2 is not a major susceptibility gene for type 2 diabetes in Pima Indians: analysis of 3,501 individuals. Diabetes (2007) 1.19
Stereotactic body radiotherapy is effective salvage therapy for patients with prior radiation of spinal metastases. Int J Radiat Oncol Biol Phys (2008) 1.19
Lupus nephritis: is the kidney biopsy currently necessary in the management of lupus nephritis? Clin J Am Soc Nephrol (2012) 1.18
Apolipoprotein L1 nephropathy risk variants associate with HDL subfraction concentration in African Americans. Nephrol Dial Transplant (2011) 1.18
Aldosterone antagonism or synthase inhibition reduces end-organ damage induced by treatment with angiotensin and high salt. Kidney Int (2009) 1.17
Immunolocalization of fibroblast growth factor-1 (FGF-1), its receptor (FGFR-1), and fibroblast-specific protein-1 (FSP-1) in inflammatory renal disease. Kidney Int (2005) 1.17
Simulated real time image guided intrafraction tracking-delivery for hypofractionated prostate IMRT. Med Phys (2008) 1.16
Inhibition of 11beta-hydroxysteroid dehydrogenase type II selectively blocks the tumor COX-2 pathway and suppresses colon carcinogenesis in mice and humans. J Clin Invest (2009) 1.14
Parietal epithelial cell activation marker in early recurrence of FSGS in the transplant. Clin J Am Soc Nephrol (2012) 1.13
Angiotensin type 1 receptor modulates macrophage polarization and renal injury in obesity. Am J Physiol Renal Physiol (2011) 1.13
Lower metabolic rate in individuals heterozygous for either a frameshift or a functional missense MC4R variant. Diabetes (2008) 1.12
Vertebral compression fracture after stereotactic body radiotherapy for spinal metastases. Lancet Oncol (2013) 1.12
Monoclonal gammopathy: significance and possible causality in renal disease. Am J Kidney Dis (2003) 1.11
Laparoscopic myotomy for achalasia: predictors of successful outcome after 200 cases. Ann Surg (2006) 1.11
An integrative genomics approach identifies activation of thioredoxin/thioredoxin reductase-1-mediated oxidative stress defense pathway and inhibition of angiogenesis in obese nondiabetic human subjects. J Clin Endocrinol Metab (2011) 1.11
Clinical implementation of intensity-modulated arc therapy. Int J Radiat Oncol Biol Phys (2002) 1.10
Weight, dietary and physical activity behaviors two years after gastric bypass. Obes Surg (2006) 1.10
A spatio-temporal dipole simulation of gastrointestinal magnetic fields. IEEE Trans Biomed Eng (2003) 1.09
Recurrent lupus nephritis in renal transplant recipients revisited: it is not rare. Transplantation (2003) 1.07
Stereotactic body radiotherapy for spinal metastases: current status, with a focus on its application in the postoperative patient. J Neurosurg Spine (2010) 1.07
Experience with the optical access trocar for safe and rapid entry in the performance of laparoscopic gastric bypass. Surg Endosc (2006) 1.06
Long-term follow-up of the metabolic profiles in obese patients with type 2 diabetes mellitus after Roux-en-Y gastric bypass. Ann Surg (2010) 1.06
Divergent effects of low versus high dose anti-TGF-beta antibody in puromycin aminonucleoside nephropathy in rats. Kidney Int (2004) 1.06
Concurrent and discrete clinicopathological presentations of Wegener granulomatosis and anti-glomerular basement membrane disease. Am J Kidney Dis (2009) 1.05
Resident training in flexible gastrointestinal endoscopy: a review of current issues and options. J Surg Educ (2007) 1.04
Oral activated charcoal adsorbent (AST-120) ameliorates extent and instability of atherosclerosis accelerated by kidney disease in apolipoprotein E-deficient mice. Nephrol Dial Transplant (2011) 1.04